Indian Patentology: A saga of evolution,compliance and harmonisation

46
NARENDRA BHATTA HL FOUNDER & CEO INDIAN PATENTOLOGY A SAGA OF EVOLUTION, COMPLIANCE AND HARMONISATION GIPC 2013, 23-30 th January 2013

description

Narendra Bhatta HL, Founder & CEO of Intellocopia IP Services (www.ipcopia.com) presented this talk on January 29th 2013 at Global IP Convention 2013 (http://iprconference.com/)

Transcript of Indian Patentology: A saga of evolution,compliance and harmonisation

Page 1: Indian Patentology: A saga of evolution,compliance and harmonisation

NARENDRA BHATTA HLFOUNDER & CEO

INDIAN PATENTOLOGY A SAGA OF

EVOLUTION, COMPLIANCE AND HARMONISATION

GIPC 2013, 23-30th January 2013

Page 2: Indian Patentology: A saga of evolution,compliance and harmonisation

2ITAG-IPCONF/BHATTA/IPCOPIA04/08/2023

Page 3: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 3

Harmonization

evolutioncompliance

INDIAN PATENTOLOGY

Page 4: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 4

Harmonization

evolution

compliance

INDIAN PATENTOLOGY

Page 5: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 5

PREAMBLE OF INDIAN CONSTITUTION:

WE, THE PEOPLE OF INDIA, having solemnly resolved to constitute India into a

SOVEREIGN SOCIALIST SECULAR DEMOCRATIC REPUBLIC

FIVE YEAR PLAN OBJECTIVES:to provide for the basic infrastructural facilities like education for all, safe drinking water, primary health care, transport, energy

Page 6: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 6

THE GREAT INDIAN BALANCING ACT

Page 7: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 7

• First Legislation in India was Act XV of 1859.• Enforced by the British Empire

on all the states ruled by the British, not entertained by the Princely States.

• The Act of 1859 provided protection for invention only and not for designs.

• The Indian Patents and Designs Act of 1911.

• Justice Rajagopala Ayyangar Committee Report of 1957 (Restrictive Patent Regime)

EVOLUTION

Page 8: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 8

EVOLUTION

• The Patents Act, 1970• Designs Act of 2000• Patent Amendment Act 2005

(Amended in order to be compliant with the TRIPS Agreement ratified by India in 1995)–Patent granted for both

product and process–Term of Patent extended to

20yrs– Incorporation of Section

3d

Page 9: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 9

EVOLUTION

1 2 3 4 5 6 7 8 9 101856 1859

18721883 1888

1911

1972

1999 2002 2005

Evolution of Indian Patent Act

year of amendment

Page 10: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 10

PATENTS:

•The Patent Office Increased its

workforce through massive

appointment of Examiners.

•IPAIRS 2.0- An Improved Search

Engine for Patents released

•Comprehensive E-filing of All

Patent Forms online ENABLED

EVOLUTION

Page 11: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 11

•CGPDTM published draft treaty

on Industrial Design Law

•Publication of Patent Applications

classified as• Ayurvedic;•Herbal;• Food;• Pharmaceuticals; and • Traditional Knowledge

EVOLUTION

Page 12: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 12

•Compulsory License issued,

to NATCO, in respect of Patent

for anti-cancer drug ‘Sorafenib’

granted to Bayer.

•Revocation of Patent no.

252093, Granted to Avesthagen,

related to ‘Ayurvedic

composition’ by Central

Government under S.66 of the

India Patent Act.

EVOLUTION

Page 13: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 13

•Publication of Processing and

Examination Guidelines in

respect of applications related to:

• Traditional knowledge and

Biological Material;

• Biotech Applications

EVOLUTION

Page 14: Indian Patentology: A saga of evolution,compliance and harmonisation

FILING TRENDS OF VARIOUS IPR IN INDIA

2006-07 2007-08 2008-09 2009-10 2010-11

28940

3521836812

34287

3940014119

11751 10296

6069

112087539

15316 16061

6168

7509

TREND OF PATENTS

FILED EXAMINED REGISTERED/GRANTED

Page 15: Indian Patentology: A saga of evolution,compliance and harmonisation

FILING TRENDS OF VARIOUS IPR IN INDIA

2006-07 2007-08 2008-09 2009-10 2010-11

55216402 6557 6092

7589

4976

6183 6446 62666277

4250

4928 4772 6025

9206

DESIGN TREND

DESIGNS FILED DESIGNS EXAMINEDDESIGNS REGISTERED/GRANTED

Page 16: Indian Patentology: A saga of evolution,compliance and harmonisation

EVOLUTION

sustained

staggered

Page 17: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 17

complianceINDIAN PATENTOLOGY

Page 18: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 18

Article 27 of the TRIPS Agreement elaborates the scope of patentable subject matter as follows:1. patents shall be available for any inventions, whether products or processes, in all fields of technology, provided that they are new, involve an inventive step and are capable of industrial application.

compliance

Page 19: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 19

2. Members may exclude from patentability inventions, the prevention within their territory of the commercial exploitation of which is necessary to protect ordre public or morality, including to protect human, animal or plant life or health or to avoid serious prejudice to the environment, provided that such exclusion is not made merely because the exploitation is prohibited by their law.

compliance

Page 20: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 20

3. Members may also exclude from patentability: •diagnostic, therapeutic and surgical methods for the treatment of humans or animals;•plants and animals other than micro-organisms, and essentially biological processes for the production of plants or animals other than non-biological and microbiological processes.

compliance

Page 21: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 21

Section 3 :(a), (b), (c), (h), (i), (j) – as per TRIPS

(k), (m)- compliant with EP

compliance

Page 22: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 22

1.Article 7 states:

’’The protection and enforcement of intellectual property rights should contribute to the promotion of technological innovation and to the transfer and dissemination of technology, to the mutual advantage of producers and users of technological knowledge and in a manner conducive to social and economic welfare, and to a balance of rights of obligations.”

compliance

Page 23: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 23

WORKING OF PATENTS S146(2)

GROUNDS FOR OPPOSITION S25(1), S25(2)

REVOCATION OF PATENT IN PUBLIC INTEREST S66.

compliance

Page 24: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 24

Article 8 states:

’’1. Members may, in formulating or amending their laws and regulations, adopt measures, necessary to protect public health and nutrition, and to promote the public interest in sectors of vital importance to their socio economic and technological development, provided that such measures are consistent with the provisions of this Agreement.’’

compliance

Page 25: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 25

(m) a mere scheme or rule or method of performing mental act or method of playing game;

(n) a presentation of information;

(o) topography of integrated circuits;

(p) an invention which, in effect, is traditional knowledge of which is an aggregation or duplication of known properties of additionally known component or components.

compliance

Page 26: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 26

Section 3d:

(d) The mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance and the mere discovery of any new property or new use for a known substance or of the mere use of a known process, machine or apparatus unless such known process results in a new product or employs at least one new reactant

compliance

Page 27: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 27

SAMPLE LIST OF PATENTS GRANTED BY

PATENT OFFICE WHICH ARE

1.NEW USE OF A KNOWN SUBSTANCE

2.COMBINATION

SOURCE: www.nipoonline.org/Section-report.doc

compliance

Page 28: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 28

NEW USE OF A KNOWN SUBSTANCE:

Page 29: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 29

COMBINATION:

Page 30: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 30

compliance

Page 31: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 31

Harmonization

INDIAN PATENTOLOG

Y

Page 32: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 32

CGPDTM allowed third party observation in respect of published PCT International Applications, as per WIPO guidelines.

Classification of Indian Patent Applications based on IPC (International Patent Classification)

Formatting of Patent Application in line with PCT format

Harmonization

Page 33: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 33

DECISIONS OF CONTROLLER, IPAB BASED ON INTERNATIONAL PRECEDENCES

Harmonization

Page 34: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 34

1. Decision : (MERCK) Schering Corp’s Patent Revoked in Cipla’s Post Grant Opposition by Chennai Patent Office – P.No. 246328“An aerosol suspension formulation for inhalation”

Parties: Schering Corp v. Cipla LimitedController: T.V Madhusudan

Grounds for revocation :1. Lack of inventive step,Obvious S.25(2)(e)2. Insufficient disclosure S.25(2)(g)TEST ADOPTED: TSM (TEACHING SUGGESTION, MOTIVATION)

Harmonization

Page 35: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 35

2. Decision :Patent no. 209251 owned by Sugen Inc. & Pharmacia & Up John co.(Later acquired Pfizer in 2002-3) for “sunitinib” was revoked on 24th Sept2012 following a post grant opposition by Cipla.Parties: Pfizer v. Cipla LimitedController: Nilanjana Mukherjee

Grounds for revocation :1. Lack of inventive step & Obvious to a person skilled in the art S.2(1)(j)IPO looked at multiple documents to highlight obviousness.Opposition board relied on Baxter Travenol Labs (Fed. Cir 1991) to establish ‘element of surprise’ .

Harmonization

Page 36: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 36

3. Decision: Patent no. 198952 owned by F.Hoffman La-Roche AG for “pegasys” wasrevoked on 2nd November 2012 following an appeal to IPAB by SankalpaRehabilitation Trust.

Parties: Sankalpa v. F.Hoffman La-Roche AGBoard: JUSTICE PRABHA SRIDEVAN

Grounds for revocation :1. Obvious to a person skilled in the art S.2(1)(j) and non-patentable u/s 3(d)US and UK judgements relied upon for test of obviousness. United States Court of Appeals for the Federal Circuit in Pfizer, Inc. v. Apotex, Inc and KSR v. Teleflex

Harmonization

Page 37: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 37

Harmonization

Page 38: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 38

Harmonization

evolutioncompliance

INDIAN PATENTOLOGY

Page 39: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 39

WHO ALL NEEDS TO EVOLVECOMPLY AND HARMONISE

Page 40: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 40

IP Rights

Investment Banker/VC

Lender Banker/

Mortgage

Customs Officials

HR Managers

Judge

Advocates/IP Attorneys

Page 41: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 41

IP

SENATORS

NGOS

COMMON PUBLIC

MEDIA

Page 42: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023ITAG-IPCONF/BHATTA/IPCOPIA 42

ABOUT US:

The word INTELLOCOPIA stands for abundance of intellect. Intellocopia IP Services is a full service establishment providing one stop solution from acquisition of IP to enforcement of IP.  Intellocopia has a team of engineers and scientists with excellent industrial experience and adequate law training. Intellocopia focuses on start-ups and SMEs. Key strengths: develop IP strategy specific to a company, sensitize workforce at all levels on nuances in IP Protection; enable in house skill development and provide cost effective solutions.

Our belief is: Protected Intellect is Power,

Protected Intellect is Wealth.

Page 43: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 43

SERVICES PROVIDED:

Development of IP Policies

IP Analysis and Review

Patent Drafting and Prosecution

Trademark , Copyright and Design

Registration.

Customized Training Sessions

Technology Transfer and Licensing

Page 44: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 44

Disclaimer

VIEWS EXPRESSED AND ERRORS, IF ANY ARE ATTRIBUTABLE TO THE AUTHOR –

IF YOU RELY ON THE ABOVE VIEWS WITHOUT A PERSONALIZED OPINION, AND IF YOU HAVE BENEFITS, YOU ARE FREE KEEP IT FOR YOURSELF WITHOUT EVEN AN ACKNOWLEDGEMENT !!

IF YOU RELY ON THE ABOVE VIEWS, SOME OF IT MAY BE WRONG AND SUFFER LOSES AND YOU SUE ME FOR NEGLIGENCE, I RESERVE not only MY RIGHTS TO RECOVER COSTS(!) but also raise new bill on you for relying upon these views!!

This presentation is primary meant for instructional use. Not for Publication. The ownership of the TM & copyrighted material (especially cartoons) appearing in the presentation is acknowledged. Thanks to the Cartoonists, a dull presentation receives an interesting touch.

Page 45: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 45

ACKNOWLEDGEMENTS:

Prof. R. Muralidharan- Mentor

Smitha HS- Associate

Page 46: Indian Patentology: A saga of evolution,compliance and harmonisation

04/08/2023 ITAG-IPCONF/BHATTA/IPCOPIA 46

CONTACT US AT

Corporate Off:-29, ‘SHESHASRI’, I ‘C’ Cross, Sn Layout, Basaveswarnagar, Bangalore-

560079Office at:-

890/4/5 , 3rd A Main, D Block, Rajajinagar II Stage, Bangalore -560010

E-mail: [email protected] ; Landline: 08023321978; Cell: +919448085810

ONLINE AND SOCIAL MEDIA CONTACT:

URL: WWW.IPCOPIA.COMFACEBOOK: http://www.facebook.com/intellocopia TWITTER: http://www.twitter.com/@ipcopia BLOG: http://ipcopia.wordpress.com